quinazolines has been researched along with allopurinol in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryan, GT; Chiu, CW; Wang, CY | 1 |
| Lee, CH; Skibo, EB | 1 |
| Ashton, WT; Hynes, JB; Jones, CW; Priest, DG | 1 |
| Alcaraz, MJ; Gonzalez-Tejero, A; Molina, P; Rioja, I; Tárraga, A; Terencio, MC; Ubeda, A | 1 |
| Chen, YZ; Li, ZR; Yap, CW | 1 |
| Catar, R; Chaykovska, L; Dragun, D; Fuller, TF; Haller, M; Hoff, U; Kusch, A; Pützer, J; Troppmair, J | 1 |
| Kaniwa, N; Saito, Y | 1 |
| Ishibashi, Y; Matsui, T; Ojima, A; Sugiura, T; Yamagishi, S | 1 |
| Kaur, G; Kumar, D; Kumar, R; Kumar, S; Negi, A; Singh, S | 1 |
| Choudhary, MI; Gul, A; Khan, KM; Saad, SM; Zafar, H | 1 |
1 review(s) available for quinazolines and allopurinol
| Article | Year |
|---|---|
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Topics: Alleles; Allopurinol; Amoxicillin-Potassium Clavulanate Combination; Azetidines; Benzylamines; Carbamazepine; Chemical and Drug Induced Liver Injury; Diclofenac; Dideoxynucleosides; Drug Hypersensitivity; Floxacillin; Genetic Markers; HLA Antigens; HLA-A Antigens; HLA-B Antigens; HLA-DQ alpha-Chains; Humans; Lapatinib; Pharmacogenetics; Quinazolines; Skin; Stevens-Johnson Syndrome; Ticlopidine | 2013 |
9 other study(ies) available for quinazolines and allopurinol
| Article | Year |
|---|---|
Nitroreduction of carcinogenic 5-nitrothiophenes by rat tissues.
Topics: Animals; Carcinogens; Cytosol; Female; In Vitro Techniques; Microsomes, Liver; Milk; Nitro Compounds; Nitrofurans; Oxidation-Reduction; Oxidoreductases; Quinazolines; Rats; Spectrophotometry, Ultraviolet; Thiophenes; Xanthine Oxidase | 1975 |
Active-site-directed reductive alkylation of xanthine oxidase by imidazo[4,5-g]quinazoline-4,9-diones functionalized with a leaving group.
Topics: Alkylation; Binding Sites; Hydrolysis; Imidazoles; Indicators and Reagents; Kinetics; Oxidation-Reduction; Quinazolines; Structure-Activity Relationship; Xanthine Oxidase | 1987 |
Quinazolines as inhibitors of xanthine oxidase.
Topics: Amines; Animals; Cattle; Chromatography, Thin Layer; Hydroxides; Milk; Quinazolines; Spectrophotometry, Ultraviolet; Xanthine Oxidase | 1974 |
Inhibition of leukocyte functions by the alkaloid isaindigotone from Isatis indigotica and some new synthetic derivatives.
Topics: Alkaloids; Animals; Brassicaceae; Cells, Cultured; Chromatography, Thin Layer; Dinoprostone; Free Radical Scavengers; Humans; Inflammation; Inflammation Mediators; Inhibitory Concentration 50; Leukocytes; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Macrophages; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Neutrophils; Nitric Oxide Synthase; Plants, Medicinal; Quinazolines; Structure-Activity Relationship; Xanthine Oxidase | 2001 |
Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods.
Topics: Adult; Algorithms; Allopurinol; Antipyrine; Carbidopa; Chlorpheniramine; Fendiline; Humans; Male; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Quinazolines; Reproducibility of Results; Statistics as Topic; Thiophenes; Tocainide | 2006 |
Protein kinase C inhibition ameliorates posttransplantation preservation injury in rat renal transplants.
Topics: Adenosine; Allopurinol; Animals; Apoptosis; Biomarkers; Blotting, Western; Cell Proliferation; Cold Temperature; Creatinine; Cytokines; Cytoprotection; Delayed Graft Function; Glutathione; Immunohistochemistry; Inflammation Mediators; Insulin; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Organ Preservation; Organ Preservation Solutions; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Raffinose; Rats; Rats, Inbred Lew; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Signal Transduction; Time Factors | 2012 |
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Hypoglycemic Agents; Linagliptin; Male; Middle Aged; Prospective Studies; Purines; Quinazolines; Uric Acid; Xanthine Oxidase | 2014 |
Synthesis and xanthine oxidase inhibitory activity of 5,6-dihydropyrazolo/pyrazolo[1,5-c]quinazoline derivatives.
Topics: Allopurinol; Enzyme Inhibitors; Free Radical Scavengers; Humans; Models, Molecular; Pyrazoles; Quinazolines; Xanthine Oxidase | 2014 |
Topics: Enzyme Inhibitors; Humans; Hyperuricemia; Molecular Docking Simulation; Quinazolines; Structure-Activity Relationship; Xanthine Oxidase | 2023 |